These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1078 related items for PubMed ID: 18499413

  • 1. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
    Höbel S, Prinz R, Malek A, Urban-Klein B, Sitterberg J, Bakowsky U, Czubayko F, Aigner A.
    Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
    [Abstract] [Full Text] [Related]

  • 2. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S, Urban-Klein B, Dai L, Höbel S, Grzelinski M, Bakowsky U, Czubayko F, Aigner A.
    J Control Release; 2006 May 15; 112(2):257-70. PubMed ID: 16574264
    [Abstract] [Full Text] [Related]

  • 3. Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery.
    Schäfer J, Höbel S, Bakowsky U, Aigner A.
    Biomaterials; 2010 Sep 15; 31(26):6892-900. PubMed ID: 20561681
    [Abstract] [Full Text] [Related]

  • 4. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S, Koburger I, John M, Czubayko F, Hadwiger P, Vornlocher HP, Aigner A.
    J Gene Med; 2010 Mar 15; 12(3):287-300. PubMed ID: 20052738
    [Abstract] [Full Text] [Related]

  • 5. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A, Merkel O, Fink L, Czubayko F, Kissel T, Aigner A.
    Toxicol Appl Pharmacol; 2009 Apr 01; 236(1):97-108. PubMed ID: 19371615
    [Abstract] [Full Text] [Related]

  • 6. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M, Lipka J, Malek A, Gutsch D, Kreyling W, Aigner A.
    Eur J Pharm Biopharm; 2011 Apr 01; 77(3):438-49. PubMed ID: 21093588
    [Abstract] [Full Text] [Related]

  • 7. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine.
    Shim MS, Kwon YJ.
    J Control Release; 2009 Feb 10; 133(3):206-13. PubMed ID: 18992289
    [Abstract] [Full Text] [Related]

  • 8. Effective polyethylenimine-mediated gene transfer into human endothelial cells.
    Zaric V, Weltin D, Erbacher P, Remy JS, Behr JP, Stephan D.
    J Gene Med; 2004 Feb 10; 6(2):176-84. PubMed ID: 14978771
    [Abstract] [Full Text] [Related]

  • 9. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A.
    J Biotechnol; 2006 Jun 25; 124(1):12-25. PubMed ID: 16413079
    [Abstract] [Full Text] [Related]

  • 10. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine.
    Alshamsan A, Haddadi A, Incani V, Samuel J, Lavasanifar A, Uludağ H.
    Mol Pharm; 2009 Jun 25; 6(1):121-33. PubMed ID: 19053537
    [Abstract] [Full Text] [Related]

  • 11. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
    Höbel S, Aigner A.
    Methods Mol Biol; 2010 Jun 25; 623():283-97. PubMed ID: 20217558
    [Abstract] [Full Text] [Related]

  • 12. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
    Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A.
    Gene Ther; 2005 Mar 25; 12(5):461-6. PubMed ID: 15616603
    [Abstract] [Full Text] [Related]

  • 13. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.
    Jiang G, Park K, Kim J, Kim KS, Oh EJ, Kang H, Han SE, Oh YK, Park TG, Kwang Hahn S.
    Biopolymers; 2008 Jul 25; 89(7):635-42. PubMed ID: 18322932
    [Abstract] [Full Text] [Related]

  • 14. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
    Ping Y, Liu C, Zhang Z, Liu KL, Chen J, Li J.
    Biomaterials; 2011 Nov 25; 32(32):8328-41. PubMed ID: 21840593
    [Abstract] [Full Text] [Related]

  • 15. N-Succinyl-chitosan grafted with low molecular weight polyethylenimine as a serum-resistant gene vector.
    Lu B, Sun YX, Li YQ, Zhang XZ, Zhuo RX.
    Mol Biosyst; 2009 Jun 25; 5(6):629-37. PubMed ID: 19462020
    [Abstract] [Full Text] [Related]

  • 16. A biodegradable low molecular weight polyethylenimine derivative as low toxicity and efficient gene vector.
    Wen Y, Pan S, Luo X, Zhang X, Zhang W, Feng M.
    Bioconjug Chem; 2009 Feb 25; 20(2):322-32. PubMed ID: 19152330
    [Abstract] [Full Text] [Related]

  • 17. Degradable polyethylenimines as DNA and small interfering RNA carriers.
    Jere D, Jiang HL, Arote R, Kim YK, Choi YJ, Cho MH, Akaike T, Cho CS.
    Expert Opin Drug Deliv; 2009 Aug 25; 6(8):827-34. PubMed ID: 19558333
    [Abstract] [Full Text] [Related]

  • 18. [Gene delivery system based on low molecular weight polyethylenimine and its transfection activity in the skin tissue].
    Liu YJ, Li YP, Li J, Jia JF, Liu L.
    Shi Yan Sheng Wu Xue Bao; 2004 Apr 25; 37(2):91-5. PubMed ID: 15259980
    [Abstract] [Full Text] [Related]

  • 19. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
    Kim SH, Jeong JH, Lee SH, Kim SW, Park TG.
    J Control Release; 2006 Nov 28; 116(2):123-9. PubMed ID: 16831481
    [Abstract] [Full Text] [Related]

  • 20. PEG- and PDMAEG-graft-modified branched PEI as novel gene vector: synthesis, characterization and gene transfection.
    Wen Y, Pan S, Luo X, Zhang W, Shen Y, Feng M.
    J Biomater Sci Polym Ed; 2010 Nov 28; 21(8-9):1103-26. PubMed ID: 20507711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.